Deferred Income Tax Liabilities, Net of Prime Medicine, Inc. from 31 Dec 2021 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary: Prime Medicine, Inc. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2021 to 31 Mar 2024.
Prime Medicine, Inc. Deferred Income Tax Liabilities, Net for the quarter ending 31 Mar 2024 was $134,000, a 74% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Income Tax Liabilities, Net, Quarterly (USD)

Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Prime Medicine, Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$134,000	+$57,000	+74%	31 Mar 2024	10-Q	10 May 2024	2024	Q1
Q4 2023	$0	-$279,000	-100%	31 Dec 2023	10-Q	10 May 2024	2024	Q1
Q3 2023	$0	-$481,000	-100%	30 Sep 2023	10-Q	03 Nov 2023	2023	Q3
Q2 2023	$108,000			30 Jun 2023	10-Q	07 Aug 2023	2023	Q2
Q1 2023	$77,000			31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$279,000	-$964,000	-78%	31 Dec 2022	10-K	01 Mar 2024	2023	FY
Q3 2022	$481,000			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q4 2021	$1,243,000			31 Dec 2021	10-K	09 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.